Stem Cells Inducing Remission for Multiple Sclerosis

HDIT/HCT is a new medical approach that is going to benefit the patients and make the work of the neurologist like Dr Shiva Vasishta easier. The treatment will induce remission of the Multiple Sclerosis.

Multiple Sclerosis is an autoimmune disease where your immune system attacks the Central Nervous System. If this happens, you will experience chronic pain, weakness and speech difficult. The condition will worsen as the years go by and can lead to disability.

With the new medical condition, neurologists will be in a position to reduce the long-term remission. The patients will get a high dose of immunosuppressive therapy, and this will be followed by a stem transplant using the patient’s blood-forming cells.

There was a five-year trial on the treatment done on different patients. 69% of the patients in the trial period reported a decrease in MS. They also said they did not experience a progression of disability or a relapse

The study was done by the National Institute of Allergy and Infectious Disease, and it indicated that this treatment could produce better results than the long term conditions. Even though the current research that was done indicate that the treatment is safe, more research is still needed to check on the associated benefits and risks if any.

About Dr Shiva Vasishta

Dr Shiva Vasishta is a neurologist, and his patients are set to benefit from this treatment. He has over 30 years of experience in the field, and that is what makes him an expert on the subject.

Dr Shiva Vasishta graduated from the Government Medical College with a Medical Degree. He is one of the doctors who practice neurology at the Kennedy University Hospital. He practices at the Eastern Neurodiagnostic Associates.

Dr Shiva Vasishta also specialises in psychiatry.

New Drug Shows Promise in Stabilizing Multiple Sclerosis

Clinical trials have shown that scientists may have finally found a breakthrough in combatting relapsing-remitting multiple sclerosis (MS). The treatments consist of a high dose immunosuppressive therapy coupled up with an implant of the patient’s blood-forming stem cells. This therapy has proven that it can lessen the effects of MS, a condition which causes the immune system to attack the nervous system.

69% of patients who tried the new drug have lived on without experiencing new MS symptoms, brain complications or advancement of neurological disability. The drug, called high-dose immunosuppressive therapy and autologous hematopoietic cell transplant (HDIT/HCT), has recorded a higher success rate than all of its competitors in the market.

The research was conducted by the National Institute of Allergy and Infectious Diseases (NIAID). Volunteers were MS patients between the age 26 and 52, who were taking other medications available which had adverse side effects to them. However, the use of HDIT/HCT proved to be safe and efficient.

The drug subdues the disease by removing the infected cell from the immune system. Doctors extract stem cells while administering the high dose therapy to suppress the immune system. The stem cells are then implanted back into the patient to reconstruct the immune system.

Realists showed massive improvements five years after taking the medication. Researchers aim to re-conduct the trial using a larger sample to increase the medication’s credibility. Although the therapy is still in its early stages, it has shown promise in the fight against MS.

Dr. Shiva’s Background

Dr. Shiva Gopal Vasishta is a neurologist based in Voorhees, New Jersey. He has practiced medicine for almost four decades. He graduated from Government Medical College in 1979.

Shiva Gopal Vasishta is a member of Medicare program hence he does not charge more than the approved amount if you are a Medicare member.

Additionally, Dr. Shiva Gopal Vasishta is an active member of the American board of psychiatry and neurology.

Thor Halvorssen’s Passion for Activism

Thor Halvorssen has made a name for himself for years by considering the needs of others. A native of Venezuela, Halvorssen has worked for years as a a Venezuelan human rights advocate and also as a film producer. Halvorssen has been an activist in the areas o public policy, individual rights and civil liberties. Halvorssen is the founder of Oslo Freedom Forum, and also serves as the is president of the Human Rights Foundation, an group devoted to global human rights. His work is far reaching he has had a major impact in numerous ways.

Thor Halvorssen’s roots take him back to Venezuela. His family was prosperous and held high position in the country. Halvorssen eventually made it to the states where he went to the University of Pennsylvania and graduated magna cum laude. Both of Halvorssen’s parents were treated unfairly during his childhood. His father was put in prison for investigating money laundering. He was beaten and tortured during the process. Halvorssen’s mother shot and wounded during a peaceful protest of the Venezuelan recall referendum back in 2004. These events appeared to have shaped Halvorssen’s passion for human rights.

In the late ninteis Halvorssen became the CEO of the Foundation for Individual Rights in Education also known as FIRE. FIRE is a U.S. organization that brought together various groups including the Heritage Foundation and the Eagle Forum. The ultimate goal was to make sure that Liberty of opinion, speech, and expression were available to all.

After years of service with FIRE Halvorssen would move on to other ventures. In 2009 he created the Oslo Freedom Forum, a group of human rights advocates. The groups work has been so impactful it was labeled a “Gathering of Heroes” by the Norwegian newspaper Verdens Gang. Halvorssen is also involved in other ventures including the Children’s Peace Movement, started in 2009 and producing movies. Halvorssen co-produced the film Freedom’s Fury and is currently producing The Moon is a Harsh Mistress, based on Robert A. Heinlein’s science fiction novel. Halvorssen’s work is far extending and continues to have an impact on many.

Maggie Gill’s Role With Memorial Health

Maggie Gill became a member of the Memorial University Medical Center in 2004. At this time she directed the finance department. In 2005, she became the CEO for the company. Her responsibilities include directing the various presidents of the company, relations, and audits. She also directs numerous medical and financial programs within the company. While there, she was the recipient of an award for outstanding performance three times. Maggie Gill’s work took her to several different hospitals in Florida.

Her Bachelor’s degree was achieved with honors when she attended Florida State University. Also with honors, she received an MBA at Saint Leo University. A program she finished at Wharton taught her how to achieve strategic thinking while in management.

Maggie Gill is The CEO of Memorial Health. In a discussion with her board, she admitted the health care field is losing money. To combat this fact, Gill came up with a different approach in July. This initiative is being called Pathways to Excellence and has already saved the company $12.6 million dollars. Included in this figure is $7.6 million dollars, a figure coming from Premier. This is a health care company out of North Carolina.

Gill’s plan is trying to achieve $20 million dollars per year with the help of Premier. The time frame is six to eighteen months and will help prepare strategies for the future of the company. Memorial needs to have a partner with financial stability or the revenue needed may be impossible to attain. The increase in patients is not a solution as one out of every three has been unable to pay their bills. The reductions form the government for medical services is having an adverse effect as well.

A new partnership has been formed between Memorial and Novant thanks to Maggie Gill. Novant offers technology based services that will help with the efficiency of Memorial Health. The purpose is to be able to offer top quality healthcare and affordable pricing. The leaders of both companies are trying to improve care for their patients while lowering the cost factors involved for both companies.

Memorial has always made patient care a top priority. The new partnership will continue this care as well as providing opportunities for future growth. Both companies are quite excited about the partnership and the opportunities it presents for the future.